<PAGE>
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 2, 2000
REGISTRATION STATEMENT NO. 333-33770
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
POST-EFFECTIVE
AMENDMENT NO. 1 TO
FORM S-3
---------------
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
MILLENNIUM PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
DELAWARE 04-3177038
(State or other jurisdiction (I.R.S. Employer
of Identification Number)
incorporation or organization)
</TABLE>
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
617-679-7000
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
JOHN B. DOUGLAS III, ESQ.
SENIOR VICE PRESIDENT AND GENERAL COUNSEL
MILLENNIUM PHARMACEUTICALS, INC.
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
(617) 679-7000
(Name, address, including zip code, and telephone
number, including area code, of Agent for Service)
------------------------
COPY TO:
DAVID E. REDLICK, ESQ.
HALE AND DORR LLP
60 STATE STREET
BOSTON, MASSACHUSETTS 02109
TELEPHONE: (617) 526-6000
------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE>
EXPLANATORY NOTE
Pursuant to a Registration Statement (the "Registration Statement") on
Form S-3 (File No. 333-33770), Millennium Pharmaceuticals, Inc. (the
"Registrant") registered shares of its common stock, $.001 par value per share
("Common Stock"), under the Securities Act of 1933, as amended, all of which
shares have been, to the Company's knowledge, sold as of the date hereof.
Pursuant to the Registrant's undertaking contained in the Registration
Statement, this Post-Effective Amendment No. 1 to Registration Statement on
Form S-3 is being filed solely to remove from registration any shares of Common
Stock which remain unsold under such Registration Statement as of the date of
this Post-Effective Amendment No. 1.
SIGNATURES
Pursuant to Rule 478 promulgated under the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets the
requirements for filing on Form S-3 and has duly caused this Post-Effective
Amendment No. 1 to Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth
of Massachusetts, on this 2nd day of October, 2000.
<TABLE>
<S> <C> <C>
MILLENNIUM PHARMACEUTICALS, INC.
By: /s/ JOHN B. DOUGLAS III
-----------------------------------------
JOHN B. DOUGLAS III
Senior Vice President and
General Counsel
</TABLE>
2
